标题
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-18
DOI
10.1038/s41579-022-00805-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
- (2022) Claudia D. Fuchs et al. Nature Reviews Gastroenterology & Hepatology
- Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
- (2022) Morgane M. Thibaut et al. TRENDS IN MOLECULAR MEDICINE
- Human gut bacteria produce ΤΗ17-modulating bile acid metabolites
- (2022) Donggi Paik et al. NATURE
- The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice
- (2021) Theresa Streidl et al. Gut Microbes
- Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization
- (2021) Matthew H. Foley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases
- (2021) Arijit A. Adhikari et al. ACS Chemical Biology
- Caloric restriction disrupts the microbiota and colonization resistance
- (2021) Reiner Jumpertz von Schwartzenberg et al. NATURE
- Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
- (2021) Hanlin Zhang et al. Experimental and Therapeutic Medicine
- Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis
- (2021) Daniel van der Lelie et al. Nature Communications
- Review: microbial transformations of human bile acids
- (2021) Douglas V. Guzior et al. Microbiome
- Dominant Bacterial Phyla from the Human Gut Show Widespread Ability To Transform and Conjugate Bile Acids
- (2021) L. N. Lucas et al. mSystems
- Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis
- (2021) Huan Zhang et al. Cell Death Discovery
- Structure, function and pharmacology of human itch GPCRs
- (2021) Can Cao et al. NATURE
- High-confidence structural annotation of metabolites absent from spectral libraries
- (2021) Martin A. Hoffmann et al. NATURE BIOTECHNOLOGY
- Global chemical effects of the microbiome include new bile-acid conjugations
- (2020) Robert A. Quinn et al. NATURE
- Mass spectrometry searches using MASST
- (2020) Mingxun Wang et al. NATURE BIOTECHNOLOGY
- Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
- (2020) Aze Wilson et al. Scientific Reports
- The microbiome modulating activity of bile acids
- (2020) Yuan Tian et al. Gut Microbes
- Intestinal bile acids directly modulate the structure and function ofC. difficileTcdB toxin
- (2020) John Tam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids
- (2020) Xi Qian et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Biogeography of microbial bile acid transformations along the murine gut
- (2020) Solenne Marion et al. JOURNAL OF LIPID RESEARCH
- A metabolic pathway for bile acid dehydroxylation by the gut microbiome
- (2020) Masanori Funabashi et al. NATURE
- Bile acids drive the newborn’s gut microbiota maturation
- (2020) N. van Best et al. Nature Communications
- Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice
- (2020) Frederik Dethloff et al. Frontiers in Psychiatry
- Exercise training reverses gut dysbiosis in patients with biopsy proven nonalcoholic steatohepatitis: A proof of concept study
- (2020) Alexa Hughes et al. Clinical Gastroenterology and Hepatology
- Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
- (2020) Junhui Yu et al. Cell Death & Disease
- Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids
- (2019) Kai Wang et al. Cell Reports
- Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
- (2019) Talima Pearson et al. Cancer Medicine
- Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
- (2019) Benjamin H Mullish et al. GUT
- Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial
- (2019) Yi Wan et al. CLINICAL NUTRITION
- Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
- (2019) Jason Lloyd-Price et al. NATURE
- MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus
- (2019) James Meixiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
- (2019) Almut Heinken et al. Microbiome
- Meta-Analysis Reveals Reproducible Gut Microbiome Alterations in Response to a High-Fat Diet
- (2019) Jordan E. Bisanz et al. Cell Host & Microbe
- Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
- (2019) Clea Bárcena et al. NATURE MEDICINE
- Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections
- (2019) John I. Robinson et al. JOURNAL OF CLINICAL INVESTIGATION
- MRGPRX4 is a bile acid receptor for human cholestatic itch
- (2019) Huasheng Yu et al. eLife
- Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition
- (2019) Akira Honda et al. JOURNAL OF LIPID RESEARCH
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
- (2019) Raul Cabrera-Rubio et al. Scientific Reports
- A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
- (2019) Ling Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
- (2018) Anna M. Seekatz et al. ANAEROBE
- Animal models to study bile acid metabolism
- (2018) Jianing Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Exercising the hepatobiliary-gut axis. The impact of physical activity performance
- (2018) Emilio Molina-Molina et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Species differences in bile acids I. Plasma and urine bile acid composition
- (2018) Rhishikesh Thakare et al. JOURNAL OF APPLIED TOXICOLOGY
- Role of Bile Acids in Metabolic Control
- (2018) Antonio Molinaro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels
- (2018) Takuya Kuno et al. Scientific Reports
- Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis
- (2018) Yan He et al. Microbiome
- Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
- (2018) Sudarshan Paramsothy et al. GASTROENTEROLOGY
- Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
- (2018) Maja Ðanić et al. Frontiers in Pharmacology
- Gut microbiome structure and metabolic activity in inflammatory bowel disease
- (2018) Eric A. Franzosa et al. Nature Microbiology
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Middle-distance running acutely influences the concentration and composition of serum bile acids: Potential implications for cancer risk?
- (2017) Elisa Danese et al. Oncotarget
- In Vitro Antibacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureus
- (2017) Thippeswamy H. Sannasiddappa et al. Frontiers in Microbiology
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis
- (2016) Guoxiang Xie et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
- (2016) Annika Wahlström et al. JOURNAL OF LIPID RESEARCH
- Human gut microbes impact host serum metabolome and insulin sensitivity
- (2016) Helle Krogh Pedersen et al. NATURE
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population-level analysis of gut microbiome variation
- (2016) Gwen Falony et al. SCIENCE
- Antibiotic Resistance and Regulation of the Gram-Negative Bacterial Outer Membrane Barrier by Host Innate Immune Molecules
- (2016) Samuel I. Miller mBio
- Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine
- (2016) Casey M. Theriot et al. mSphere
- Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China
- (2016) Jing Xiao et al. Scientific Reports
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- A biosynthetic pathway for a prominent class of microbiota-derived bile acids
- (2015) A Sloan Devlin et al. Nature Chemical Biology
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- Bile acids and the gut microbiome
- (2014) Jason M. Ridlon et al. CURRENT OPINION IN GASTROENTEROLOGY
- Meta-analyses of human gut microbes associated with obesity and IBD
- (2014) William A. Walters et al. FEBS LETTERS
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- FXR is a molecular target for the effects of vertical sleeve gastrectomy
- (2014) Karen K. Ryan et al. NATURE
- The gut microbiota, bacterial metabolites and colorectal cancer
- (2014) Petra Louis et al. NATURE REVIEWS MICROBIOLOGY
- Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut
- (2014) S. A. Joyce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
- (2014) Chiara Degirolamo et al. Cell Reports
- Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection
- (2013) Alexa R. Weingarden et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
- (2013) Anne Vrieze et al. JOURNAL OF HEPATOLOGY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
- (2013) Katharine M. Ng et al. NATURE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2013) Yongjie Ma et al. PHARMACEUTICAL RESEARCH
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
- (2012) M L Jones et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice
- (2012) Farzad Alemi et al. GASTROENTEROLOGY
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer
- (2011) Caroline B. Appleyard et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect of Antibiotic Treatment on the Intestinal Metabolome
- (2011) L. Caetano M. Antunes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice
- (2011) Maxi Meissner et al. ATHEROSCLEROSIS
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells
- (2011) Andrea Mencarelli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis
- (2011) Sigurd Lax et al. INTERNATIONAL JOURNAL OF CANCER
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Activation of the Wnt/ -Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
- (2011) A. Wolfe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probiotics Modulate Intestinal Expression of Nuclear Receptor and Provide Counter-Regulatory Signals to Inflammation-Driven Adipose Tissue Activation
- (2011) Andrea Mencarelli et al. PLoS One
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
- (2010) Daniel R. Schmidt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
- (2010) J. R. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
- (2010) M. Vijay-Kumar et al. SCIENCE
- Physical Activity as a Determinant of Fecal Bile Acid Levels
- (2009) B. C. Wertheim et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- The enterohepatic circulation of bile acids in mammals: form and functions
- (2009) Alan et al. Frontiers in Bioscience-Landmark
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Caffeinated energy drinks—A growing problem
- (2008) Chad J. Reissig et al. DRUG AND ALCOHOL DEPENDENCE
- Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores
- (2008) J. A. Sorg et al. JOURNAL OF BACTERIOLOGY
- Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
- (2008) R. R.M. Maran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome
- (2008) B. V. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started